Key facts
- It has raised $20K; the latest was Early Stage VC in Oct 2025.
- Notable investors include 1985 Capital, Breakthrough Lab, Brown University.
- Status: Privately Held (backing).
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for day-guard
- ·The full record, as it builds
Funding rounds
No funding rounds for day-guard are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About day-guard
Operator of a pre-alcohol vitamin jelly designed to support liver function and gut health before drinking. The company offers a doctor-formulated blend of antioxidants, electrolytes, and prebiotics, enabling health-conscious social drinkers to reduce next-day discomfort, bloating, and alcohol-related skin issues.
- Sector
- Consumer Products and Services (B2C)
- HQ
- Dover, DE, United States
- Founded
- 2023
- Employees
- 3
- Website
- dayguard.com/
- Ownership
- Privately Held (backing)
day-guard doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in day-guard shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on day-guard in its N-PORT filings yet. We sweep new filings monthly.